BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23269581)

  • 1. A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.
    Ouyang L; Liu P; Yang S; Ye S; Xu W; Liu X
    Med Oncol; 2013 Mar; 30(1):340. PubMed ID: 23269581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer.
    Shigehara K; Yokomuro S; Ishibashi O; Mizuguchi Y; Arima Y; Kawahigashi Y; Kanda T; Akagi I; Tajiri T; Yoshida H; Takizawa T; Uchida E
    PLoS One; 2011; 6(8):e23584. PubMed ID: 21858175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of the combination of circulating serum miRNAs and CA125 in endometriosis.
    Chen G; Guo J; Li W; Zheng R; Shang H; Wang Y
    Medicine (Baltimore); 2023 Dec; 102(48):e36339. PubMed ID: 38050316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
    Lian F; Cui Y; Zhou C; Gao K; Wu L
    PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of serum microRNA-21 as a biomarker for chemosensitivity and prognosis in human osteosarcoma.
    Yuan J; Chen L; Chen X; Sun W; Zhou X
    J Int Med Res; 2012; 40(6):2090-7. PubMed ID: 23321165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review.
    Zhou G; Shi X; Zhang J; Wu S; Zhao J
    J Int Med Res; 2013 Feb; 41(1):1-12. PubMed ID: 23569124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
    Pan W; Wang H; Jianwei R; Ye Z
    Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polymorphism site in the pre‑miR‑34a coding region reduces miR‑34a expression and promotes osteosarcoma cell proliferation and migration.
    Lv H; Pei J; Liu H; Wang H; Liu J
    Mol Med Rep; 2014 Dec; 10(6):2912-6. PubMed ID: 25242229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells.
    Fujiwara T; Katsuda T; Hagiwara K; Kosaka N; Yoshioka Y; Takahashi RU; Takeshita F; Kubota D; Kondo T; Ichikawa H; Yoshida A; Kobayashi E; Kawai A; Ozaki T; Ochiya T
    Stem Cells; 2014 Apr; 32(4):959-73. PubMed ID: 24715690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells.
    Wang J; Xu G; Shen F; Kang Y
    Tumour Biol; 2014 May; 35(5):4859-65. PubMed ID: 24449507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma.
    Yang J; Gao T; Tang J; Cai H; Lin L; Fu S
    Mol Cell Biochem; 2013 Sep; 381(1-2):9-15. PubMed ID: 23801049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects.
    Miao J; Wu S; Peng Z; Tania M; Zhang C
    Tumour Biol; 2013 Aug; 34(4):2093-8. PubMed ID: 23797816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell.
    Jianwei Z; Fan L; Xiancheng L; Enzhong B; Shuai L; Can L
    Tumour Biol; 2013 Dec; 34(6):3331-7. PubMed ID: 23740615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether à go-go 1 expression.
    Wu X; Zhong D; Gao Q; Zhai W; Ding Z; Wu J
    Int J Med Sci; 2013; 10(6):676-82. PubMed ID: 23569431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma.
    Zhou G; Lu M; Chen J; Li C; Zhang J; Chen J; Shi X; Wu S
    Tumour Biol; 2015 Nov; 36(11):8845-52. PubMed ID: 26069101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum miR-195 is a diagnostic and prognostic marker for osteosarcoma.
    Cai H; Zhao H; Tang J; Wu H
    J Surg Res; 2015 Apr; 194(2):505-510. PubMed ID: 25498513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating and extracellular vesicle-derived microRNAs as biomarkers in bone-related diseases.
    Huber J; Longaker MT; Quarto N
    Front Endocrinol (Lausanne); 2023; 14():1168898. PubMed ID: 37293498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-143 expression inhibits the growth and the invasion of osteosarcoma.
    Zhang P; Zhang J; Quan H; Wang J; Liang Y
    J Orthop Surg Res; 2022 Apr; 17(1):236. PubMed ID: 35418302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Significance of miR-21 in Guiding Chemotherapy for Patients with Osteosarcoma.
    Li LZ; Wu ZZ; Lv Z
    Pharmgenomics Pers Med; 2021; 14():1247-1261. PubMed ID: 34616172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.